BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 7851831)

  • 1. [Ion channels of vascular smooth muscle and pharmacological effects of calcium antagonists and potassium channel openers].
    Kitamura K; Ogata R
    Fukuoka Igaku Zasshi; 1994 Nov; 85(11):309-13. PubMed ID: 7851831
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of K-channel openers on the contractility and electrical activity of antral circular muscle in guinea-pig stomach.
    Kim KW; Kim SJ; Jun JY
    J Smooth Muscle Res; 1993 Oct; 29(5):145. PubMed ID: 8167416
    [No Abstract]   [Full Text] [Related]  

  • 3. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
    Nielsen-Kudsk JE
    Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ca-antagonist, K-channel-opener in the treatment of patients with congestive heart failure].
    Satoh K
    Nihon Rinsho; 1993 May; 51(5):1293-8. PubMed ID: 8331797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. K(+)-channel activators in vascular smooth muscle.
    Cox RH
    Prog Clin Biol Res; 1990; 334():171-85. PubMed ID: 2309006
    [No Abstract]   [Full Text] [Related]  

  • 6. Modulation of guinea-pig tracheal smooth muscle responsiveness by the potassium channel openers NIP-121 and cromakalim.
    Shikada K; Yamamoto A; Tanaka S
    Jpn J Pharmacol; 1992; 58 Suppl 2():334P. PubMed ID: 1507583
    [No Abstract]   [Full Text] [Related]  

  • 7. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
    Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R
    J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of BRL 38227 on K-currents in rat portal vein.
    Edwards G; Noack T; Deitmer P; Weston AH
    Jpn J Pharmacol; 1992; 58 Suppl 2():336P. PubMed ID: 1507585
    [No Abstract]   [Full Text] [Related]  

  • 9. Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts?
    Tosaki A; Szerdahelyi P; Engelman RM; Das DK
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1355-62. PubMed ID: 8263798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cromakalim does not act as a calcium antagonist in isolated human mesenteric artery cells.
    Smirnov SV; Aaronson PI; Russell SN
    Eur J Pharmacol; 1992 Jun; 217(1):105-8. PubMed ID: 1327816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Potassium agonists].
    Hellwig B
    Med Monatsschr Pharm; 1994 Jun; 17(6):164-7. PubMed ID: 8052166
    [No Abstract]   [Full Text] [Related]  

  • 12. Potassium channel activators in vascular smooth muscle.
    Cox RH
    Adv Exp Med Biol; 1991; 308():27-43. PubMed ID: 1801587
    [No Abstract]   [Full Text] [Related]  

  • 13. Demonstration of the potassium channel opening activity of GYKI-12743 by 86Rb+ efflux studies.
    Bakonyi A; Horváth EJ
    Acta Physiol Hung; 1994; 82(4):295-300. PubMed ID: 7785439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do potassium channel openers compete with ATP to activate ATP sensitive potassium channels?
    Henry P; Escande D
    Cardiovasc Res; 1994 Jun; 28(6):754-9. PubMed ID: 7923275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glyburide-reversible cardioprotective effect of BMS-180448 is independent of action potential shortening.
    Grover GJ; D'Alonzo AJ; Hess T; Sleph PG; Darbenzio RB
    Cardiovasc Res; 1995 Nov; 30(5):731-8. PubMed ID: 8595620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Ca2+-activated K+ channel from rabbit aorta: modulation by cromakalim.
    Gelband CH; Lodge NJ; Van Breemen C
    Eur J Pharmacol; 1989 Aug; 167(2):201-10. PubMed ID: 2591475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of adenosine-triphosphate-sensitive potassium channels in the mechanical responses of agonist-stimulated isolated porcine coronary arteries.
    Nguyen DH
    Arzneimittelforschung; 1997 Dec; 47(12):1351-8. PubMed ID: 9450163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of the potassium channel activator cromakalim on human isolated bronchial smooth muscle].
    Luo Y; Liu J; Zhou L
    Zhonghua Jie He He Hu Xi Za Zhi; 1995 Jun; 18(3):149-51, 189. PubMed ID: 8565081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of potassium channel openers and calcium channel blockers on the force responses of the electrically driven rat right ventricle strip.
    Bishop BE; Doggrell SA
    J Auton Pharmacol; 1992 Feb; 12(1):5-14. PubMed ID: 1551924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotective effects of a novel calcium antagonist related to the structure of cromakalim.
    Grover GJ; Sleph PG; Dzwonczyk S; McCullough JR
    J Pharmacol Exp Ther; 1993 Oct; 267(1):102-7. PubMed ID: 8229736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.